Plandai Biotechnology, Inc. Provides Year-End Shareholder Update
31 déc. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
LOGAN, UT--(Marketwired - December 31, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Uruguay's Presidential Election Favors Plandai Biotechnology's Future Cannabis Research
04 déc. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - December 04, 2014) - Timing is everything and when Plandaí Biotechnology (OTCQB: PLPL) was given the go-ahead to grow cannabis for medical research in Uruguay, little did...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
18 nov. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
Plandai Biotechnology Collaboration Offers Opportunity to Produce a Non-Psychoactive Cannabis Product for Medical Research
10 nov. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has entered into a collaboration agreement in Uruguay that will give the company the potential to produce a...
Plandai Biotechnology, Inc. Receives Approval to Grow Cannabis for Medical Research From Uruguay's Ministry of Public Health
29 oct. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 29, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product
26 juin 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently learned that it qualifies for an exemption that will allow the company to commence sales of its...
Plandai Biotechnology up for $2.5 Million Grant in Continued Support From South African Government
02 mai 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 2, 2014) - Plandaí Biotechnology (OTCQB: PLPL) could soon receive another injection of money from the South African government, and this time it's in the form...
Plandai Biotechnology Recruiting Now for Human Clinical Trials to Begin in May
30 avr. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 30, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has been given the go-ahead to conduct human clinical trials in a 3-month study that will compare the oral...
Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in New Facility
04 avr. 2014 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 4, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with a brand new state of the art production facility that is due to be fully...
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
26 mars 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 26, 2014) - What may have been lost in Plandaí Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging...